MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines.

Almhanna, Khaldoun; Cubitt, Christopher L.; Zhang, Shumin; Kazim, Sabiha; Husain, Kazim; Sullivan, Dan; Sebti, Said; Malafa, Mokenge

Cancer Biology & Therapy, 2013, Vol 14, Issue 10, p932

1538-4047

Academic Journal

10.4161/cbt.25939